Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Mandel

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Free Radical Biology & Medicine|June 30, 2004
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseasesSilvia Mandel, Moussa B H Youdim
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2003
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cellsOrly Weinreb, Silvia Mandel, Moussa B H Youdim
Trends in Pharmacological Sciences|April 23, 2003
Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugsSilvia Mandel, Orly Weinreb, Moussa B H Youdim
Annals of the New York Academy of Sciences|July 11, 2003
Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatoninOrly Weinreb, Silvia Mandel, Moussa B H Youdim
Drug Discovery Today|April 12, 2013
Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugsSilvia Mandel, Orly Weinreb, Moussa B H Youdim
Journal of Molecular Neuroscience : MN|January 19, 2005
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallateSilvia Mandel, Gila Maor, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa YoudimOrly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Archives of Gerontology and Geriatrics|December 11, 2012
Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adultsPerla Werner, Shira Goldberg, Silvia Mandel, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discoverySilvia Mandel, Tamar Amit, Limor Kalfon, et al.
Genes & Nutrition|September 17, 2009
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic propertiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Free Radical Biology & Medicine|June 30, 2004
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseasesSilvia Mandel, Moussa B H Youdim
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2003
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cellsOrly Weinreb, Silvia Mandel, Moussa B H Youdim
Trends in Pharmacological Sciences|April 23, 2003
Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugsSilvia Mandel, Orly Weinreb, Moussa B H Youdim
Annals of the New York Academy of Sciences|July 11, 2003
Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatoninOrly Weinreb, Silvia Mandel, Moussa B H Youdim
Drug Discovery Today|April 12, 2013
Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugsSilvia Mandel, Orly Weinreb, Moussa B H Youdim
Journal of Molecular Neuroscience : MN|January 19, 2005
Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallateSilvia Mandel, Gila Maor, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa YoudimOrly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Archives of Gerontology and Geriatrics|December 11, 2012
Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adultsPerla Werner, Shira Goldberg, Silvia Mandel, et al.
Expert Opinion on Drug Discovery|March 19, 2013
Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discoverySilvia Mandel, Tamar Amit, Limor Kalfon, et al.
Genes & Nutrition|September 17, 2009
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic propertiesOrly Weinreb, Tamar Amit, Silvia Mandel, et al.
Pageof 5